Fmc-376

Advanced Solid Tumors With KRAS G12C Mutations

Frontier Medicines CorporationPhase 1/2

—

Rating in progress

Fmc-376 in Advanced Solid Tumors With KRAS G12C Mutations is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.

Methodology v0.2 · Active